{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:04:11Z","timestamp":1790679851135,"version":"4.1.0"},"reference-count":65,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2015.00035","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T10:58:15Z","timestamp":1423652295000},"source":"Crossref","is-referenced-by-count":51,"title":["Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia"],"prefix":"10.3389","volume":"6","author":[{"given":"Daniela S.","family":"Ardelean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Letarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1160\/TH11-11-0809","article-title":"Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.","volume":"108","author":"Albinana","year":"2012","journal-title":"Thromb. Haemost."},{"key":"B2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/mol.110.067447","article-title":"Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-beta1 signaling in endothelial cells.","volume":"79","author":"Albinana","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10456-013-9383-4","article-title":"Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.","volume":"17","author":"Ardelean","year":"2014a","journal-title":"Angiogenesis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10456-014-9421-x","article-title":"Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis.","volume":"17","author":"Ardelean","year":"2014b","journal-title":"Angiogenesis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/eji.1830210228","article-title":"The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.","volume":"21","author":"Bierer","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMc0901421","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia.","volume":"360","author":"Bose","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2141.2009.07730.x","article-title":"Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?","volume":"146","author":"Bowcock","year":"2009","journal-title":"Br. J. Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease.","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1177\/0091270011417824","article-title":"Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review.","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/lary.21345","article-title":"Safety of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.","volume":"121","author":"Chen","year":"2011","journal-title":"Laryngoscope"},{"issue":"e88511","key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088511","article-title":"Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2605.1996.tb00466.x","article-title":"Leydig cells secrete factors which increase vascular permeability and endothelial cell proliferation.","volume":"19","author":"Collin","year":"1996","journal-title":"Int. J. Androl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis.","volume":"91","author":"D\u00e2\u20ac\u2122Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.4161\/mabs.28025","article-title":"ELLIPSE Study: a phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.","volume":"6","author":"Dupuis-Girod","year":"2014","journal-title":"MAbs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors.","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11239-012-0840-5","article-title":"Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.","volume":"36","author":"Franchini","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1083\/jcb.104.3.689","article-title":"Inhibition of endothelial cell proliferation by gamma-interferon.","volume":"104","author":"Friesel","year":"1987","journal-title":"J. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.114.303984","article-title":"Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models\u00e2\u20ac\u201cbrief report.","volume":"34","author":"Garrido-Martin","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","article-title":"Hereditary haemorrhagic telangiectasia: a clinical and scientific review.","volume":"17","author":"Govani","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-014-9436-3","article-title":"VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.","volume":"17","author":"Han","year":"2014","journal-title":"Angiogenesis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2169\/internalmedicine.52.8555","article-title":"The efficacy of oral tacrolimus in patients with moderate\/severe ulcerative colitis not receiving concomitant corticosteroid therapy.","volume":"52","author":"Inoue","year":"2013","journal-title":"Intern. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/cvr\/cvr232","article-title":"Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.","volume":"92","author":"Jerkic","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1016\/j.lfs.2005.10.016","article-title":"Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells.","volume":"78","author":"Komorowski","year":"2006","journal-title":"Life Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"H959","DOI":"10.1152\/ajpheart.01251.2009","article-title":"The physiological role of endoglin in the cardiovascular system.","volume":"299","author":"Lopez-Novoa","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0162-3109(91)90040-6","article-title":"Propranolol treatment affects parameters of human immunity.","volume":"22","author":"Maisel","year":"1991","journal-title":"Immunopharmacology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00004836-200404000-00015","article-title":"Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C.","volume":"38","author":"Massoud","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/lt.21417","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.","volume":"14","author":"Mitchell","year":"2008","journal-title":"Liver Transpl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0030-1253454","article-title":"Heterogeneity of the tumor vasculature.","volume":"36","author":"Nagy","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"B34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","article-title":"Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.","volume":"97","author":"Oh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.amjoto.2011.10.011","article-title":"Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.","volume":"33","author":"Olitsky","year":"2012","journal-title":"Am.J.Otolaryngol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMc091271","article-title":"More on bevacizumab in hereditary hemorrhagic telangiectasia.","volume":"361","author":"Oosting","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1904","key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.155","article-title":"A case of hereditary hemorrhagic telangiectasia associated with Crohn\u00e2\u20ac\u2122s disease successfully treated with infliximab.","volume":"105","author":"Papa","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1172\/JCI39482","article-title":"Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.","volume":"119","author":"Park","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.3748\/wjg.v19.i31.5051","article-title":"Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.","volume":"19","author":"Pavlidis","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling.","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2147\/DDDT.S55458","article-title":"Update on the clinical utility of once-daily tacrolimus in the management of transplantation.","volume":"8","author":"Posadas Salas","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2006.11.015","article-title":"The gonadotropins: tissue-specific angiogenic factors?","volume":"269","author":"Reisinger","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"issue":"931","key":"B44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMc091271","article-title":"More on bevacizumab in hereditary hemorrhagic telangiectasia.","volume":"361","author":"Retornaz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ajg.2011.48","article-title":"Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn\u00e2\u20ac\u2122s disease.","volume":"106","author":"Rutella","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B46","first-page":"15","article-title":"Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density.","volume":"15","author":"Sadick","year":"2005a","journal-title":"Int. J. Mol. Med."},{"key":"B47","first-page":"818","article-title":"Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.","volume":"90","author":"Sadick","year":"2005b","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists.","volume":"301","author":"Scallon","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"21264","DOI":"10.1073\/pnas.0907550106","article-title":"Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.","volume":"106","author":"Schonthaler","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1182\/blood-2009-01-199166","article-title":"Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.","volume":"114","author":"Shao","year":"2009","journal-title":"Blood"},{"issue":"e20412","key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020412","article-title":"The role of calcineurin\/NFAT in SFRP2 induced angiogenesis\u00e2\u20ac\u201ca rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.","volume":"6","author":"Siamakpour-Reihani","year":"2011","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/lary.20159","article-title":"The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.","volume":"119","author":"Simonds","year":"2009","journal-title":"Laryngoscope"},{"key":"B53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7326\/0003-4819-144-3-200602070-00030","article-title":"Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia.","volume":"144","author":"Skaro","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0012-1606(03)00158-1","article-title":"Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor.","volume":"261","author":"Sorensen","year":"2003","journal-title":"Dev. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.","volume":"163","author":"Storch","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"365","key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08481.x","article-title":"Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia.","volume":"152","author":"Suppressa","year":"2011","journal-title":"Br. J. Haematol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5527\/wjn.v1.i6.177","article-title":"Treatment of young patients with lupus nephritis using calcineurin inhibitors.","volume":"1","author":"Tanaka","year":"2012","journal-title":"World J. Nephrol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1208\/aapsj070103","article-title":"Properties of thalidomide and its analogues: implications for anticancer therapy.","volume":"7","author":"Teo","year":"2005","journal-title":"AAPS J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/ATVBAHA.109.200121","article-title":"Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia.","volume":"30","author":"Toporsian","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"e98646","key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098646","article-title":"Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression.","volume":"9","author":"Tual-Chalot","year":"2014","journal-title":"PLoS ONE"},{"key":"B61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.mcg.0000155137.73433.36","article-title":"Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia.","volume":"39","author":"Wheatley-Price","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases.","volume":"165","author":"Willrich","year":"2014","journal-title":"Transl. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjd.12193","article-title":"Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147.","volume":"168","author":"Xie","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1182\/blood-2004-09-3679","article-title":"Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate.","volume":"106","author":"Yabu","year":"2005","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1523-1747.2003.12045.x","article-title":"Thrombospondin-1 plays a critical role in the induction of hair follicle involution and vascular regression during the catagen phase.","volume":"120","author":"Yano","year":"2003","journal-title":"J. Invest. Dermatol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"deposited":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T11:48:55Z","timestamp":1425383335000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fgene.2015.00035\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,11]]},"references-count":65,"URL":"https:\/\/doi.org\/10.3389\/fgene.2015.00035","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,11]]}}}